Xyall
PrivateLast Round
Series C
Feb 11, 2026
Total Funding Raised
$20.87M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xyall is a medtech company that develops and provides automated tissue dissection solutions for molecular pathology testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Workflow Automation, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xyall Comparables
Compare Xyall with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 75% | |
| Zeiss | 71% | |
| Morphle Labs | 71% |
Xyall Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 11, 2026 | ||||
| Series B | May 24, 2022 | ||||
| Series A | Jan 13, 2020 |
Xyall Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series B |
| Capricorn Partners | Series C |
| BOM Brabant Ventures | Series C, Series A |
| Health Investment Partners | Series C, Series B |
| Netherlands Enterprise Agency | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 12, 48% of headcount.
- Aug 1, 2026
Grew 19% QoQ, from 21 to 25 employees.
Recent news
Latest coverage and updates
- is_developingSep 17, 2026
Xyall BV will develop end-to-end solution for automating macro-dissection on Oct 1st '26.
Xyall Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xyall's valuation, stock price, and market status.
Is Xyall a public or private company?
Xyall is a private company.
What is the current stock price of Xyall?
Xyall is a private company with no public stock price. No recent secondary market data is available.
How much is Xyall worth (valuation)?
Valuation information for Xyall is not publicly available.
Can I buy Xyall stock?
Xyall shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xyall's last funding round?
Funding round information for Xyall is not publicly available.
Who are the main investors in Xyall?
Investor information for Xyall is not publicly disclosed.
Will Xyall IPO soon?
No public IPO plans have been announced for Xyall.
How can I track Xyall secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xyall's secondary market activity and sign up for updates.